cytarabine has been researched along with 3-deazauridine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (91.30) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, PD; McNamara, DJ | 1 |
| Bloch, A | 1 |
| Brockman, RW; Nelson, JA; Rose, LM; Schabel, FM; Shaddix, SC; Williams, M | 1 |
| Jackson, RC; Weber, G; Williams, JC | 1 |
| Lauzon, GJ; Paran, JH; Paterson, AR | 1 |
| Belch, AW; Lauzon, GJ; Paterson, AR | 1 |
| Chabner, BA; Drake, JC; Hande, KR | 1 |
| Jakobs, ES; Lauzon, GJ; Paterson, AR; Weinstein, WM | 1 |
| Lauzon, GJ; Mills-Yamamoto, C; Paterson, AR | 1 |
| Bouffard, DY; Marie, JP; Marquet, J; Momparler, LF; Momparler, RL; Zittoun, J; Zittoun, R | 1 |
| Grem, JL; Harrison, SD; Hawkins, MJ; Plowman, J; Rubinstein, L | 1 |
| Moriconi, WJ; Slavik, M; Taylor, S | 1 |
| Momparler, LF; Momparler, RL | 1 |
| Campbell, J; Mayhew, E; Radel, S; Rustum, YM | 1 |
| Baker, MA; Chang, G; Grant, S; Hindenburg, AA; Taub, RN | 1 |
| Bouchard, J; Chabot, GG; Momparler, RL | 1 |
| Campbell, J; Li, ZR; Rustum, YM | 1 |
| Cysyk, RL; Hoerauf, RM; Karle, JM | 1 |
| Lauzon, GJ; Paterson, AR; Yang, S | 1 |
| Barlogie, B; Chubb, S; Plunkett, W | 1 |
| Harrap, KR; Renshaw, J | 1 |
| Brockman, RW; Corbett, TH; Griswold, DP; Laster, WR; Schabel, FM; Skipper, HE; Trader, MW | 1 |
| Barlogie, B; Keating, M; Latreille, J; McCredie, K; Plunkett, W; Raber, M | 1 |
2 review(s) available for cytarabine and 3-deazauridine
| Article | Year |
|---|---|
The structure of nucleosides in relation to their biological and and biochemical activity: a summary.
Topics: 3-Deazauridine; Adenine; Adenosine; Anti-Bacterial Agents; Azacitidine; Cytarabine; Idoxuridine; Isopentenyladenosine; Nucleosides; Pseudouridine; Puromycin; Structure-Activity Relationship; Tubercidin; Uridine | 1975 |
Intracellular nucleotide pools and their significance in antimetabolite therapy.
Topics: 3-Deazauridine; Animals; Antimetabolites, Antineoplastic; Cell Cycle; Coformycin; Cricetinae; Cricetulus; Cytarabine; HeLa Cells; Humans; Leukemia L1210; Methotrexate; Nucleic Acids; Pyrimidine Nucleotides | 1980 |
21 other study(ies) available for cytarabine and 3-deazauridine
| Article | Year |
|---|---|
Synthesis and antitumor activity of fluorine-substituted 4-amino-2(1H)-pyridinones and their nucleosides. 3-Deazacytosines.
Topics: Animals; Antimetabolites, Antineoplastic; Cytosine; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Spectrophotometry; Structure-Activity Relationship | 1987 |
The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Topics: 3-Deazauridine; Adenocarcinoma; Animals; Cell Line; Cytarabine; Deoxycytidine; Deoxyribonucleotides; DNA, Neoplasm; Drug Resistance; Leukemia L1210; Liver; Mice; Neoplasms, Experimental; Orotic Acid; Phosphotransferases; Pyrimidine Nucleotides; Ribonucleotide Reductases; Ribonucleotides; RNA, Neoplasm; Uracil Nucleotides; Uridine | 1975 |
Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosamine.
Topics: 3-Deazauridine; Carcinoma, Hepatocellular; Cell Line; Cytarabine; Drug Combinations; Drug Synergism; Galactosamine; Half-Life; Liver Neoplasms; Uracil Nucleotides; Uridine | 1976 |
Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
Topics: 3-Deazauridine; Animals; Cell Division; Cells, Cultured; Choline; Cytarabine; Cytidine Diphosphate Choline; Drug Synergism; Humans; Hydrolysis; Leukemia, Experimental; Leukemia, Myeloid, Acute | 1978 |
Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
Topics: 3-Deazauridine; Animals; Choline; Cytarabine; Cytidine Diphosphate Choline; Drug Synergism; Female; HeLa Cells; Leukemia L1210; Leukemia, Experimental; Leukemia, Myeloid, Acute; Liver; Lymphocytes; Mice; Mice, Inbred Strains | 1978 |
Ara-C metabolism: implications for drug resistance and drug interactions.
Topics: 3-Deazauridine; Animals; Cytarabine; Cytidine Deaminase; Drug Interactions; Drug Resistance; Humans; Mice; Neoplasms; Tetrahydrouridine | 1979 |
Drug sequence-dependent toxicity and small bowel mucosal injury in mice treated with low doses of 3-deazauridine and 1-beta-D-arabinofuranosylcytosine.
Topics: 3-Deazauridine; Animals; Cytarabine; Female; Intestinal Mucosa; Intestine, Small; Male; Mice; Thioinosine; Time Factors; Uridine | 1979 |
Toxicity of combinations of arabinosylcytosine and 3-deazauridine toward neoplastic cells in culture.
Topics: 3-Deazauridine; Antineoplastic Agents; Cytarabine; Drug Resistance; Drug Synergism; HeLa Cells; Uridine; Uridine Kinase | 1978 |
Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine.
Topics: 3-Deazauridine; Cell Line; Cell Survival; Cytarabine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute | 1991 |
Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia model.
Topics: 3-Deazauridine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytidine; Drug Resistance; Drug Synergism; Female; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Remission Induction; Survival Rate | 1991 |
3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
Topics: 3-Deazauridine; Acute Disease; Animals; Antineoplastic Agents; Azacitidine; Cytarabine; Decitabine; Drug Evaluation; Drug Synergism; Galactosamine; Humans; Kinetics; Leukemia; Neoplasms; Thymidine; Uridine | 1986 |
Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
Topics: 3-Deazauridine; Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Line; Cytarabine; Decitabine; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Tumor Cells, Cultured | 1989 |
Approaches to overcome in vivo anti-cancer drug resistance.
Topics: 3-Deazauridine; Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cell Line; Cytarabine; Doxorubicin; Drug Resistance; Drug Synergism; Fluorouracil; Leucovorin; Leukemia L1210; Liposomes; Mice; Verapamil | 1986 |
Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells.
Topics: 3-Deazauridine; Agglutination; Antimetabolites, Antineoplastic; Cell Line; Cytarabine; Cytidine Triphosphate; Doxorubicin; Glucosamine; Humans; Isoxazoles; Lectins; Leukemia, Myeloid, Acute; N-Acetylneuraminic Acid; Pyrimidines; Sialic Acids | 1985 |
Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.
Topics: 3-Deazauridine; Adult; Arabinofuranosyluracil; Azacitidine; Cytarabine; Cytidine Deaminase; Cytosine; Decitabine; Humans; Kinetics; Liver; Nucleoside Deaminases; Substrate Specificity; Thymidine | 1983 |
Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Topics: 3-Deazauridine; Animals; Azacitidine; Chromatography, High Pressure Liquid; Cytarabine; Drug Therapy, Combination; Lethal Dose 50; Leukemia L1210; Mice; Mice, Inbred DBA; Purine Nucleotides; Pyrimidine Nucleotides; Uridine | 1983 |
Labelling of the thymidine and deoxycytidine bases of DNA by [2-14C]deoxycytidine in cultured L1210 cells.
Topics: 3-Deazauridine; Animals; Carbon Radioisotopes; Cytarabine; Cytidine; Deoxycytidine; DNA; Leukemia L1210; Mice; Tetrahydrouridine; Thymidine | 1983 |
Cell cycle arrest as a basis of enhancement of 1-beta-D-arabinofuranosylcytosine anabolism in human lymphoblastoid RPMI 6410 cells cultured with 3-deazauridine.
Topics: 3-Deazauridine; Cell Cycle; Cell Division; Cells, Cultured; Cytarabine; HeLa Cells; Humans; Kinetics; Lymphoma, Non-Hodgkin; Neoplasms, Experimental; Phosphorylation; Time Factors; Uridine | 1981 |
Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
Topics: 3-Deazauridine; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cells, Cultured; Chromatography, High Pressure Liquid; Cytarabine; Cytidine Triphosphate; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Uracil Nucleotides; Uridine; Uridine Triphosphate | 1980 |
Drug control of Ara-C-resistant tumor cells.
Topics: 3-Deazauridine; Adenocarcinoma; Animals; Anthraquinones; Antimetabolites, Antineoplastic; Colonic Neoplasms; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Leukemia L1210; Mice; Mitoxantrone; Neoplasms, Experimental | 1982 |
In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
Topics: 3-Deazauridine; Adolescent; Adult; Aged; Cell Cycle; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Metabolic Clearance Rate; Middle Aged; Uridine | 1981 |